Preclinical research: Make mouse studies work
Copyright policy )Preclinical research: Make mouse studies work
More investment to characterize animal models can boost the ability of preclinical work to predict drug effects in humans, says Steve Perrin.
- Amyotrophic Lateral Sclerosis Therapy Development Institute United States
- ALS Therapy Alliance United States
Clinical Trials as Topic, Dose-Response Relationship, Drug, Superoxide Dismutase, Amyotrophic Lateral Sclerosis, Drug Evaluation, Preclinical, Reproducibility of Results, Guidelines as Topic, Survival Analysis, Translational Research, Biomedical, Disease Models, Animal, Mice, Superoxide Dismutase-1, Organ Specificity, Research Design, Cause of Death, Disease Progression, Animals, Humans, False Positive Reactions, Half-Life
Clinical Trials as Topic, Dose-Response Relationship, Drug, Superoxide Dismutase, Amyotrophic Lateral Sclerosis, Drug Evaluation, Preclinical, Reproducibility of Results, Guidelines as Topic, Survival Analysis, Translational Research, Biomedical, Disease Models, Animal, Mice, Superoxide Dismutase-1, Organ Specificity, Research Design, Cause of Death, Disease Progression, Animals, Humans, False Positive Reactions, Half-Life
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).596 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1%
Citations provided by BIP!Popularity provided by BIP!